Total Payments
$9,487
2024 Payments
$1,349
Companies
39
Transactions
592
Medicare Patients
2,069
Medicare Billing
$425,790
Payment Breakdown by Category
Food & Beverage$9,424 (99.3%)
Education$62.26 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,424 | 587 | 99.3% |
| Education | $62.26 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,606 | 73 | $0 (2024) |
| Relypsa, Inc. | $1,072 | 115 | $0 (2020) |
| Vifor Pharma, Inc. | $804.98 | 108 | $0 (2024) |
| Amgen Inc. | $750.09 | 51 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $532.76 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $454.70 | 22 | $0 (2024) |
| NxStage Medical, Inc. | $346.75 | 7 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $344.51 | 11 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $337.94 | 20 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $311.28 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,349 | 65 | AstraZeneca Pharmaceuticals LP ($380.71) |
| 2023 | $1,320 | 69 | AstraZeneca Pharmaceuticals LP ($234.69) |
| 2022 | $2,000 | 108 | AstraZeneca Pharmaceuticals LP ($364.82) |
| 2021 | $1,123 | 86 | Vifor Pharma, Inc. ($336.80) |
| 2020 | $635.83 | 45 | AstraZeneca Pharmaceuticals LP ($168.80) |
| 2019 | $1,118 | 74 | Relypsa, Inc. ($509.07) |
| 2018 | $1,297 | 88 | Relypsa, Inc. ($321.95) |
| 2017 | $643.44 | 57 | Amgen Inc. ($219.65) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.62 | General |
| Category: NEPHROLOGY | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: NEPHROLOGY | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Nephrology | ||||||
| 11/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $6.01 | General |
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.26 | General |
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.80 | General |
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.27 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEPHROLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/26/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Hyperkalemia | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: NEPHROLOGY | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 359 | 1,052 | $153,263 | $86,246 |
| 2022 | 8 | 494 | 1,506 | $162,298 | $93,570 |
| 2021 | 8 | 552 | 1,493 | $200,796 | $118,973 |
| 2020 | 10 | 664 | 1,965 | $257,121 | $127,001 |
Total Patients
2,069
Total Services
6,016
Medicare Billing
$425,790
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 512 | $84,872 | $42,881 | 50.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 48 | 113 | $48,025 | $31,190 | 64.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 29 | $11,020 | $6,653 | 60.4% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 15 | 358 | $4,536 | $2,657 | 58.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $2,625 | $1,615 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $2,185 | $1,249 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 320 | $51,200 | $27,443 | 53.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 37 | 92 | $39,100 | $25,951 | 66.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 266 | $30,590 | $14,979 | 49.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 46 | $17,480 | $11,055 | 63.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 26 | $9,880 | $5,899 | 59.7% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 21 | 716 | $9,072 | $5,344 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $4,704 | $2,839 | 60.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 15 | 16 | $272.00 | $59.74 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 354 | $56,640 | $31,576 | 55.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 49 | 108 | $45,900 | $30,695 | 66.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 203 | 333 | $38,295 | $19,953 | 52.1% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 15 | 74 | $28,120 | $17,632 | 62.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 32 | 49 | $18,620 | $11,307 | 60.7% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 20 | 527 | $6,677 | $4,068 | 60.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $6,272 | $3,677 | 58.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 16 | 16 | $272.00 | $64.32 | 23.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 91 | 222 | $94,350 | $50,480 | 53.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 160 | 280 | $44,800 | $20,145 | 45.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 223 | 351 | $40,365 | $16,950 | 42.0% |
About Dionicio Alvarez
Dionicio Alvarez is a Nephrology healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275504490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dionicio Alvarez has received a total of $9,487 in payments from pharmaceutical and medical device companies, with $1,349 received in 2024. These payments were reported across 592 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,424).
As a Medicare-enrolled provider, Alvarez has provided services to 2,069 Medicare beneficiaries, totaling 6,016 services with total Medicare billing of $425,790. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location El Paso, TX
- Active Since 01/27/2006
- Last Updated 08/23/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1275504490
Products in Payments
- Veltassa (Drug) $1,859
- LOKELMA (Drug) $997.97
- FARXIGA (Drug) $608.50
- Kerendia (Drug) $532.76
- JYNARQUE (Drug) $454.70
- Auryxia (Drug) $436.41
- KRYSTEXXA (Biological) $405.62
- Parsabiv (Biological) $344.92
- BENLYSTA (Biological) $289.65
- Velphoro (Drug) $289.46
- GATTEX (Drug) $263.15
- AURYXIA (Drug) $212.81
- Parsabiv (Drug) $186.30
- TARPEYO (Drug) $176.67
- ACTHAR (Biological) $164.23
- KEVEYIS (Drug) $155.12
- NXSTAGE SYSTEM ONE (Device) $134.44
- MOUNJARO (Drug) $125.00
- JARDIANCE (Drug) $117.56
- IBSRELA (Drug) $113.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in El Paso
Mr. Fernando Raudales, M.d, M.D
Nephrology — Payments: $30,477
Nephrology $30,477
Diane Demick, Md, MD
Nephrology — Payments: $21,349
Nephrology $21,349
Dr. Lisa Hechanova, M.d, M.D
Nephrology — Payments: $9,405
Nephrology $9,405
Mr. Jorge Serna, M.d, M.D
Nephrology — Payments: $8,962
Nephrology $8,962
Dr. Simon Rodriguez, M.d, M.D
Nephrology — Payments: $8,724
Nephrology $8,724
Mrs. Ileana Martinez, M.d, M.D
Nephrology — Payments: $7,029
Nephrology $7,029